SCHEMBL12219429

SCHEMBL12219429

c1ccc2c(c1)Cc1c-2c2[nH]c3ccccc3c2c2c1[nH]c1ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K9 P80192 6/20 0.66
▸ MAP3K11 Q16584 6/20 0.66
▸ PRKD3 O94806 5/20 0.66
▸ PRKCG P05129 5/20 0.66
▸ PRKCB P05771 5/20 0.66
▸ PRKCA P17252 5/20 0.66
▸ PRKCH P24723 5/20 0.66
▸ PRKCI P41743 5/20 0.66
▸ PRKCE Q02156 5/20 0.66
▸ PRKCQ Q04759 5/20 0.66
▸ PRKCZ Q05513 5/20 0.66
▸ PRKCD Q05655 5/20 0.66
▸ PRKD1 Q15139 5/20 0.66
▸ MAP3K10 Q02779 4/20 0.66
▸ KDR P35968 3/20 0.66
▸ NTRK1 P04629 2/20 0.66
▸ CA1 P00915 4/20 0.57
▸ CA2 P00918 4/20 0.57
▸ CA4 P22748 4/20 0.57
▸ CA6 P23280 4/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23369901 0.89 MAP3K9 (0.61) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL17228824 0.89 MAP3K9 (0.64) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL17451746 0.83 MAP3K9 (0.61) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL3075228 0.82 MAP3K9 (0.80) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL20382171 0.82 MAP3K9 (0.57) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL7354146 0.82 MAP3K9 (0.68) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL3082217 0.80 MAP3K9 (1.00) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL3072275 0.80 MAP3K11 (1.00) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL2466653 0.78 MAP3K9 (0.61) MAP3K9MAP3K11PRKD3PRKCGPRKCB
SCHEMBL5173554 0.78 MAP3K9 (0.61) MAP3K9MAP3K11PRKD3PRKCGPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169206-B2 Organic semiconductor compound, method for preparing the same, and organic semiconductor composition, and organic semiconductor thin film and element containing the same LUMINANO CO., LTD. (KR) 2015-10-27 — — US disclosed
US-20110253944-A1 NOVEL ORGANIC SEMICONDUCTOR COMPOUND, METHOD FOR PREPARING SAME, AND ORGANIC SEMICONDUCTOR COMPOSITION, AND ORGANIC SEMICONDUCTOR THIN FILM AND ELEMENT CONTAINING THE SAME LUMINANO CO., LTD. (KR) 2011-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110253944-A1 NOVEL ORGANIC SEMICONDUCTOR COMPOUND, METHOD FOR PREPARING SAME, AND ORGANIC SEMICONDUCTOR COMPOSITION, AND ORGANIC SEMICONDUCTOR THIN FILM AND ELEMENT CONTAINING THE SAME TYR, FTO, PIEZO1 MAP3K9 2184/4885MAP3K11 2312/4885PRKD3 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback